公开(公告)号：US20240150405A1

公开(公告)日：2024-05-09

申请号：US18492612

申请日：2023-10-23

Applicant: Janssen Biotech, Inc. ,  Protagonist Therapeutics, Inc.

Inventor： Chengzao SUN ,  Brian Troy FREDERICK ,  Sandeep SOMANI ,  Gregory Thomas BOURNE ,  Raymond PATCH ,  Ashok BHANDARI ,  Raffaele INGENITO ,  Roberto COSTANTE ,  Danila BRANCA ,  Elisabetta BIANCHI

IPC: C07K7/64

CPC classification number: C07K7/64 ,  A61K38/00

Abstract: The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases.

公开(公告)号：US20240383954A1

公开(公告)日：2024-11-21

申请号：US18657493

申请日：2024-05-07

Applicant: Janssen Biotech, Inc. ,  Protagonist Therapeutics, Inc.

Inventor： Chengzao SUN ,  Brian Troy FREDERICK ,  Sandeep SOMANI ,  Ashok BHANDARI ,  Raymond PATCH ,  Stephanie BARROS ,  Raffaele INGENITO ,  Roberto COSTANTE ,  Danila BRANCA ,  Elisabetta BIANCHI

IPC: C07K14/47 ,  A61K38/00 ,  A61K47/60

Abstract: The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases.